Korro Bio(KRRO)
$14.41-1.32 (-8.39%)
KRRO
Korro Bio financials statements
$14.41
At close:-1.32 (-8.39%)
Want to see KRRO full AI Analyst Report?
Korro Bio (KRRO) Ratios
578 Followers
Korro Bio Ratios
KRRO's free cash flow for Q3 2026 was $-12.96M. For the 2026 fiscal year, KRRO's free cash flow was decreased by $-27.00K and operating cash flow was $-12.94M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.90 | 8.79 | 8.87 | 6.56 | 11.79 |
| Quick Ratio | 6.90 | 8.79 | 8.87 | 6.56 | 11.79 |
| Cash Ratio | 1.83 | 3.72 | 8.53 | 4.25 | 6.97 |
| Solvency Ratio | -1.82 | -1.22 | -1.50 | -0.32 | -1.48 |
| Operating Cash Flow Ratio | -6.58 | -4.02 | -3.45 | -6.17 | -2.81 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -18.37 | -12.44 |
| Net Current Asset Value | $ 20.30M | $ 65.71M | $ 120.98M | $ -115.69M | $ 80.21M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.38 | 0.20 | 0.15 | 2.26 | 0.25 |
| Debt-to-Equity Ratio | 0.85 | 0.28 | 0.20 | -1.69 | 0.35 |
| Debt-to-Capital Ratio | 0.46 | 0.22 | 0.16 | 2.46 | 0.26 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 2.53 | 0.10 |
| Financial Leverage Ratio | 2.21 | 1.41 | 1.30 | -0.74 | 1.42 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | -18.59 | -23.95 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -499.98 | -109.99 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 3.40 | 0.01 |
| Interest Debt Per Share | 4.63 | 5.02 | 21.72 | 655.34 | 10.43 |
| Net Debt to EBITDA | -0.26 | 0.12 | 1.64 | -2.30 | 0.43 |
| Profitability Margins | |||||
| Gross Profit Margin | 33.04% | 100.00% | 0.00% | 0.00% | 72.70% |
| EBIT Margin | -1366.43% | -4047.12% | 0.00% | 0.00% | -596.44% |
| EBITDA Margin | -1299.47% | -3890.14% | 0.00% | 0.00% | -569.14% |
| Operating Profit Margin | -1366.43% | -4047.12% | 0.00% | 0.00% | -597.32% |
| Pretax Profit Margin | -1824.52% | -3674.15% | 0.00% | 0.00% | -601.87% |
| Net Profit Margin | -1834.48% | -3680.36% | 0.00% | 0.00% | -601.98% |
| Continuous Operations Profit Margin | -1834.48% | -3680.36% | 0.00% | 0.00% | -601.98% |
| Net Income Per EBT | 100.55% | 100.17% | 100.03% | 100.02% | 100.02% |
| EBT Per EBIT | 133.52% | 90.78% | 95.99% | 98.35% | 100.76% |
| Return on Assets (ROA) | -103.31% | -36.94% | -36.62% | -78.70% | -45.69% |
| Return on Equity (ROE) | -227.96% | -52.10% | -47.77% | 58.60% | -64.73% |
| Return on Capital Employed (ROCE) | -85.99% | -43.50% | -41.81% | -90.71% | -48.31% |
| Return on Invested Capital (ROIC) | -83.79% | -43.24% | -41.40% | -86.81% | -47.61% |
| Return on Tangible Assets | -103.31% | -36.94% | -36.62% | -78.70% | -45.69% |
| Earnings Yield | -155.81% | -24.61% | -108.03% | -118.22% | -7.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.60 | 1.34 | 0.00 | 0.00 | 97.69 |
| Payables Turnover | 2.59 | 0.00 | 0.00 | 0.00 | 1.40 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.39 | 0.04 | 0.00 | 0.00 | 0.38 |
| Asset Turnover | 0.06 | 0.01 | 0.00 | 0.00 | 0.08 |
| Working Capital Turnover Ratio | 0.07 | 0.02 | 0.00 | 0.00 | 0.09 |
| Cash Conversion Cycle | -85.47 | 272.58 | 0.00 | 0.00 | -257.40 |
| Days of Sales Outstanding | 55.33 | 272.58 | 0.00 | 0.00 | 3.74 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 140.80 | 0.00 | 0.00 | 0.00 | 261.14 |
| Operating Cycle | 55.33 | 272.58 | 0.00 | 0.00 | 3.74 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -8.36 | -6.73 | -44.00 | -210.37 | -7.22 |
| Free Cash Flow Per Share | -8.42 | -8.74 | -49.13 | -230.81 | -8.22 |
| Dividend Paid and CapEx Coverage Ratio | -151.66 | -3.36 | -8.59 | -10.29 | -7.22 |
| Capital Expenditure Coverage Ratio | -151.66 | -3.36 | -8.59 | -10.29 | -7.22 |
| Operating Cash Flow Coverage Ratio | -1.81 | -1.34 | -2.03 | -0.32 | -0.70 |
| Operating Cash Flow to Sales Ratio | -12.29 | -26.45 | 0.00 | 0.00 | -2.28 |
| Free Cash Flow Yield | -105.08% | -22.96% | -99.98% | -119.90% | -3.20% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.64 | -4.06 | -0.93 | -0.85 | -13.47 |
| Price-to-Sales (P/S) Ratio | 11.77 | 149.54 | 0.00 | 0.00 | 81.08 |
| Price-to-Book (P/B) Ratio | 1.46 | 2.12 | 0.44 | -0.50 | 8.72 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.95 | -4.36 | -1.00 | -0.83 | -31.22 |
| Price-to-Operating Cash Flow Ratio | -0.96 | -5.65 | -1.12 | -0.92 | -35.54 |
| Price-to-Earnings Growth (PEG) Ratio | -0.02 | 0.05 | 0.01 | -0.00 | 0.15 |
| Enterprise Value Multiple | -1.17 | -3.72 | 0.71 | -3.17 | -13.82 |
| Enterprise Value | 96.92M | 328.73M | -57.81M | 179.14M | 1.11B |
| EV to EBITDA | -1.17 | -3.72 | 0.71 | -3.17 | -13.82 |
| EV to Sales | 15.16 | 144.75 | 0.00 | 0.00 | 78.66 |
| EV to Free Cash Flow | -1.23 | -4.22 | 0.77 | -3.04 | -30.28 |
| EV to Operating Cash Flow | -1.23 | -5.47 | 0.86 | -3.34 | -34.48 |
| Tangible Book Value Per Share | 5.47 | 17.98 | 111.13 | -388.36 | 29.42 |
| Shareholders’ Equity Per Share | 5.47 | 17.98 | 111.13 | -388.36 | 29.42 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.68 | 0.25 | 0.00 | 0.00 | 3.16 |
| Net Income Per Share | -12.48 | -9.37 | -53.09 | -227.58 | -19.04 |
| Tax Burden | 1.01 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.34 | 0.91 | 0.96 | 0.98 | 1.01 |
| Research & Development to Revenue | 10.26 | 28.02 | 0.00 | 0.00 | 4.22 |
| SG&A to Revenue | 4.41 | 13.45 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 1.20 | 1.96 | 0.00 | 0.00 | 0.06 |
| Income Quality | 0.67 | 0.72 | 0.83 | 0.92 | 1.46 |
Currency in USD
